An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer.

An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer. Acta Oncol. 2020 Oct 12;:1-5 Authors: Heervä E, Väliaho V, Salminen T, Nieminen L, Carpelan A, Kurki S, Sundström J, Huhtinen H, Rantala A, Carpén O, Minn H, Österlund P, Ålgars A, Ristamäki R PMID: 33044880 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33044880?dopt=Abstract

Source: Acta Oncologica - October 12, 2020 Category: Cancer & Oncology Authors: Heervä E, Väliaho V, Salminen T, Nieminen L, Carpelan A, Kurki S, Sundström J, Huhtinen H, Rantala A, Carpén O, Minn H, Österlund P, Ålgars A, Ristamäki R Tags: Acta Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer